https://www.selleckchem.com/products/phtpp.html
Sacral neuromodulation (SNM) and Botulinum toxin A (BoNT-A) injections are well-known third-line treatment options in patients with refractory overactive bladder (OA. Our aim is to evaluate the success rate of SNM in patients who received prior therapy with BoNT-A injections. All patients with OAB symptoms referred for SNM between 2006 and 2019 were included. History taking and 3-day voiding diaries assessed the complaints and suitability for SNM. The success rate of SNM in patients who received prior BoNT-A was compared with BoNT-A nai
Curtir
Comentario
Compartilhar
